Detail Information of Xenobiotics

General Information of Xenobiotics (ID: XEO05224)
Xenobiotics Name
Vancomycin
Xenobiotics Type
Pharmaceutical Agent(s)
Classification
Approved/Marketed Drug
Structure
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=14969"></iframe>
3D MOL 2D MOL
PubChem CID
14969
DME(s) Modulated by This Xenobiotics
DME(s) Inhibited by This Xenobiotics
Azoreductase (azoR) DME Info Enterococcus faecalis [1]
Unclear metabolic mechanism (DME-unclear) DME Info Enterococcus faecalis [1]
NADPH-dependent oxidoreductase (nfrA) DME Info Staphylococcus aureus [2]
Tyrosine decarboxylase (tdc) DME Info Enterococcus faecalis [1]
VanA ligase (vanA) DME Info Enterococcus faecalis [1]
VanB ligase (vanB) DME Info Enterococcus faecalis [1]
References
1 BMAP-28 improves the efficacy of vancomycin in rat models of gram-positive cocci ureteral stent infection. Peptides. 2008 Jul;29(7):1118-23.
2 Pre-treatment of central venous catheters with the cathelicidin BMAP-28 enhances the efficacy of antistaphylococcal agents in the treatment of experimental catheter-related infection. Peptides. 2006 Sep;27(9):2104-10.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.